BLRX

BioLineRX
BLRX

Overview Fund Activity

15 hedge funds and large institutions have $6.74M invested in BioLineRX in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 13 closing their positions.

Holders
15
Holders Change
-9
Holders Change %
-37.5%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
–
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$384K
2
EMG
2
ETF Managers Group
New Jersey
$123K
3
NFG
3
Next Financial Group
Texas
$20K
4
UBS Group
4
UBS Group
Switzerland
$3K
5
ADL
5
Asset Dedication LLC
California
$1K

Top Sellers

1
FI
1
Fosun International
China
$0
2
SAM
2
Sectoral Asset Management
Quebec, Canada
$0
3
Geode Capital Management
3
Geode Capital Management
Massachusetts
$0
4
CCB
4
Cutter & Co Brokerage
Missouri
$0
5
MCC
5
Malaga Cove Capital
California
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
FWM
26
Focused Wealth Management
New York
– -$2K -8 Closed
DWM
27
Doyle Wealth Management
Florida
– -$1K -5 Closed
1
2